CTI Biopharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsCTI Biopharma

CTI Biopharma(CTIC)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Vonjo	Pacritinib	2022-02-28	2028-2030	Primary myelofibrosis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

non-hodgkin lymphoma

,

,

b-cell lymphoma

colorectal neoplasms

,

pancreatic neoplasms

,

,

cholangiocarcinoma

Aglatimagene besadenovec

,

,

head and neck neoplasms

,

esophageal neoplasms

,

disease progression

,

neuroendocrine carcinoma

,

castration-resistant prostatic neoplasms

,

,

,

large b-cell lymphoma diffuse

,

urogenital neoplasms

,

male genital neoplasms

,

,

small cell lung carcinoma

,

renal cell carcinoma

,

male genital diseases

,

prostatic diseases

,

abdominal neoplasms

,

genital diseases

,

,

myelomonocytic leukemia chronic

,

systemic mastocytosis

,

myelomonocytic leukemia juvenile

,

hypereosinophilic syndrome

,

,

dermatofibrosarcoma

,

hematologic neoplasms

,

,

b-cell lymphoma

,

neuroendocrine tumors

,

renal insufficiency

,

urologic neoplasms

,

kidney neoplasms

,

endometrial neoplasms

,

t-cell lymphoma

,

malignant mesothelioma

,

clear cell adenocarcinoma

,

,

adenomyoepithelioma

,

,

thrombocytopenia

,

,

,

x-linked bulbo-spinal atrophy

,

,

,

,

,

,

bone resorption

,

,

prostatic neoplasms

,

neoplasm metastasis

,

breast neoplasms

,

,

bone marrow diseases

,

multiple myeloma

,

second primary neoplasms

,

plasma cell neoplasms

,

hypersensitivity

,

,

,

,

major depressive disorder

,

depressive disorder

,

non-small-cell lung carcinoma

multiple myeloma

,

plasma cell neoplasms

non-hodgkin lymphoma

,

b-cell lymphoma marginal zone

,

follicular lymphoma

breast neoplasms

,

,

neoplasm metastasis

kidney diseases

,

renal insufficiency

,

pharmacokinetics

pancreatic neoplasms

,

drug-related side effects and adverse reactions

,

,

sezary syndrome

,

mycosis fungoides

,

t-cell lymphoma cutaneous

,

healthy volunteers/patients

,

triple negative breast neoplasms

,

pancreatic neoplasms

,

adenocarcinoma of lung

,

bronchiolo-alveolar adenocarcinoma

,

stomach neoplasms

,

head and neck neoplasms

,

squamous cell carcinoma of head and neck

,

non-small-cell lung carcinoma

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

,

,

colorectal neoplasms

,

ovarian neoplasms

,

fallopian tube neoplasms

,

peritoneal neoplasms

,

,

,

female genital neoplasms

,

pelvic neoplasms

,

,

small cell carcinoma

,

small cell lung carcinoma

,

,

depressive disorder

,

rheumatoid arthritis

,

,

,

unknown primary neoplasms

,

,

renal insufficiency

,

cholangiocarcinoma

,

gallbladder neoplasms

,

breast neoplasms

,

,

neoplasm metastasis

,

major depressive disorder

,

,

,

attention deficit disorder with hyperactivity

neoplasm metastasis

,

1

2

3

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use